Acromegaly and cancer: An old debate revisited

European Journal of Endocrinology

Volumn 175, Issue 4, 2016, Pages R147-R156

  Boguszewski, Cesar Luiz ^a   Ayuk, John ^b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; AGING; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; DISEASE ACTIVITY; DISEASE CONTROL; EPIGENETICS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; MORTALITY RATE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; THYROID CANCER; TREATMENT OUTCOME; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; COMORBIDITY; FEMALE; INCIDENCE; MALE; MORTALITY; PROSTATIC NEOPLASMS; RISK; THYROID NEOPLASMS;

ACROMEGALY; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; PROSTATIC NEOPLASMS; RISK; THYROID NEOPLASMS;

EID: 84990033491     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-16-0178     Document Type: Review

References (76)

1. Capatina C & Wass JA. 60 years of Neuroendocrinology: acromegaly. Journal of Endocrinology 2015 226 141-160. (doi:10.1530/JOE-15-0109)
2. Holdaway IM, Bolland MJ & Gamble GD. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. European Journal of Endocrinology 2008 159 89-95. (doi:10.1530/EJE-08-0267)
3. Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS & Stewart PM. Mortality in patients with pituitary disease. Endocrine Reviews 2010 31 301-342. (doi:10.1210/er.2009-0033)
4. Colao A, Ferone D, Marzullo P & Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews 2004 25 102-152. (doi:10.1210/er.2002-0022)
5. Kopchick JJ, List EO, Kelder B, Gosney ES & Berryman DE. Evaluation of growth hormone (GH) action in mice: discovery of GH receptor antagonists and clinical indications. Molecular and Cellular Endocrinology 2014 386 34-45. (doi:10.1016/j.mce.2013.09.004)
6. Clayton PE, Banerjee I, Murray PG & Renehan AG. Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nature Reviews Endocrinology 2011 7 11-24. (doi:10.1038/nrendo.2010.171)
7. Jenkins PJ & Besser M. Clinical perspective: acromegaly and cancer: a problem. Journal of Clinical Endocrinology and Metabolism 2001 86 2935-2941.
8. Jenkins PJ, Mukherjee A & Shalet SM. Does growth hormone cause cancer? Clinical Endocrinology 2006 64 115-121. (doi:10.1111/cen. 2006.64.issue-2)
9. Renehan AG & Brennan BM. Acromegaly, growth hormone and cancer risk. Best Practice and Research Clinical Endocrinology and Metabolism 2008 22 639-657 (doi:10.1016/j.beem.2008.08.011)
10. Loeper S & Ezzat S. Acromegaly: re-thinking the cancer risk. Reviews in Endocrine and Metabolic Disorders 2008 9 41-58. (doi:10.1007/s11154-007-9063-z)
11. Melmed S. Acromegaly and cancer: not a problem? Journal of Clinical Endocrinology and Metabolism 2001 86 2929-2934. (doi:10.1210/jcem.86.7.7635)
12. Mustacchi P & Shimkin MB. Occurrence of cancer in acromegaly and in hypopituitarism. Cancer 1957 10 100-104. (doi:10.1002/ (ISSN) 1097-0142)
13. Nabarro JDN. Acromegaly. Clinical Endocrinology 1987 26 481-512. (doi:10.1111/j.1365-2265.1987.tb00805.x)
14. Ritchie CM, Atkinson AB, Kennedy AL, Lyons AR, Gordon DS, Fannin T & Hadden DR. Ascertainment and natural history of treated acromegaly in Northern Ireland. Ulster Medical Journal 1990 59 55-62.
15. Barzilay J, Heatley GJ & Cushing GW. Benign and malignant tumors in patients with acromegaly. Archives of Internal Medicine 1991 151 1629-1632. (doi:10.1001/archinte.1991.00400080113022)
16. Ron E, Gridley G, Hrubec Z, Page W, Arora S & Fraumeni JF Jr. Acromegaly and gastrointestinal cancer. Cancer 1991 68 1673-1677. (doi:10.1002/1097-0142 (19911015) 68:8<1673::AID-CNCR2820680802>3.0. CO;2-0)
17. Cheung NW & Boyages SC. Increased incidence of neoplasia in females with acromegaly. Clinical Endocrinology 1997 47 323-327. (doi:10.1046/j.1365-2265.1997.2561053.x)
18. Orme SM, McNally RJ, Cartwright RA & Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism 1998 83 2730-2734. (doi:10.1210/jcem.83.8.5007)
19. Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M, Obradovic S, Zoric S, Simic M, Penezic Z et al. Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clinical Endocrinology 1998 49 441-445. (doi:10.1046/j.1365-2265.1998.00536.x)
20. Higuchi Y, Saeki N, Iuchi T, Uchino Y, Tatsuno I, Uchida D, Tanaka T, Noguchi Y, Nakamura S, Yasuda T et al. Incidence of malignant tumors in patients with acromegaly. Endocrine Journal 2000 47 (Supplement) S57-S60. (doi:10.1507/endocrj.47. SupplMarch-S57)
21. Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A, Olsen JH, Baron JA & Fraumeni JF Jr. Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 2002 13 395-400. (doi:10.1023/A:1015713732717)
22. Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T, Moreno B et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). European Journal of Endocrinology 2004 151 439-446. (doi:10.1530/eje.0.1510439)
23. Kauppinen-Makelin R, Sane T, Valimaki MJ, Markkanen H, Niskanen L, Ebeling T, Jaatinen P, Juonala M, Pukkala E & Finnish Acromegaly Study Group. Increased cancer incidence in acromegaly - a nationwide survey. Clinical Endocrinology 2010 72 278-279. (doi:10.1111/j.1365-2265.2009.03619.x)
24. Gullu BE, Celik O, Gazioglu N & Kadioglu P. Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 2010 13 242-248. (doi:10.1007/s11102-010-0224-9)
25. Baldys-Waligorska A, Krzentowska A, Golkowski F, Sokolowski G & Hubalewska-Dydejczyk A. The prevalence of benign and malignant neoplasms in acromegalic patients. Endokrynologia Polska 2010 61 29-34.
26. Dagdelen S, Cinar N & Erbas T. Increased thyroid cancer risk in acromegaly. Pituitary 2014 17 299-306. (doi:10.1007/s11102-013-0501-5)
27. Mercado M, Gonzalez B, Vargas G, Ramirez C, de los Monteros AL, Sosa E, Jervis P, Roldan P, Mendoza V, Lopez-Felix B et al. Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. Journal of Clinical Endocrinology and Metabolism 2014 99 4438-4446. (doi:10.1210/jc.2014-2670)
28. Petroff D, Tonjes A, Grussendorf M, Droste M, Dimopoulou C, Stalla G, Jaursch-Hancke C, Mai M, Schopohl J & Schofl C. The incidence of cancer among acromegaly patients: results from the German Acromegaly Registry. Journal of Clinical Endocrinology and Metabolism 2015 100 3894-3902. (doi:10.1210/jc.2015-2372)
29. Patel JD, Krilov L, Adams S, Aghajanian C, Basch E, Brose MS, Carroll WL, de Lima M, Gilbert MR, Kris MG et al. Clinical cancer advances 2013: annual report on progress against cancer from the American Society of Clinical Oncology. Journal of Clinical Oncology 2014 32 129-160. (doi:10.1200/JCO.2013.53.7076)
30. Torre LA, Siegel RL, Ward EM & Jemal A. Global cancer incidence and mortality rates and trends: an update. Cancer Epidemiology, Biomarkers and Prevention 2016 25 16-27 (doi:10.1158/1055-9965. EPI-15-0578)
31. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A & Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2016 pii: gutjnl-2015-310912 (doi: 10.1136/gutjnl-2015-310912)
32. Holdaway IM, Rajasoorya RC & Gamble GD. Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 667-674. (doi:10.1210/jc.2003-031199)
33. Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavo S et al. Predictors of morbidity and mortality in acromegaly: an Italian survey. European Journal of Endocrinology 2012 167 189-198. (doi:10.1530/EJE-12-0084)
34. Tezcan G, Tunca B, Ak S, Cecener G & Egeli U. Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer. World Journal of Gastrointestinal Oncology 2016 8 83-98. (doi:10.4251/wjgo.v8.i1.83)
35. Zhang K, Civan J, Mukherjee S, Patel F & Yang H. Genetic variations in colorectal cancer risk and clinical outcome. World Journal of Gastroenterology 2014 20 4167-4177. (doi:10.3748/wjg.v20.i15.4167)
36. Chan AT & Giovannucci EL. Primary prevention of colorectal cancer. Gastroenterology 2010 138 2029-2043.e10 (doi:10.1053/j. gastro.2010.01.057)
37. Delhougne B, Deneux C, Abs R, Chanson P, Fierens H, Laurent-Puig P, Duysburgh I, Stevenaert A, Tabarin A, Delwaide J et al. The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients. Journal of Clinical Endocrinology and Metabolism 1995 80 3223-3226. (doi:10.1210/jcem.80.11.7593429)
38. Jenkins PJ, Fairclough PD, Richards T, Lowe DG, Monson J, Grossman A, Wass JA & Besser M., Acromegaly colonic polyps and carcinoma. Clinical Endocrinology 1997 47 17-22. (doi:10.1046/j.1365-2265.1997.1911029.x)
39. Terzolo M, Reimondo G, Gasperi M, Cozzi R, Pivonello R, Vitale G, Scillitani A, Attanasio R, Cecconi E, Daffara F et al. Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy. Journal of Clinical Endocrinology and Metabolism 2005 90 84-90. (doi:10.1210/jc.2004-0240)
40. Renehan AG, Bhaskar P, Painter JE, O'Dwyer ST, Haboubi N, Varma J, Ball SG & Shalet SM. The prevalence and characteristics of colorectal neoplasia in acromegaly. Journal of Clinical Endocrinology and Metabolism 2000 85 3417-3424. (doi:10.1210/jc.85.9.3417)
41. Rokkas T, Pistiolas D, Sechopoulos P, Margantinis G & Koukoulis G. Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World Journal of Gastroenterology 2008 14 3484-3489.
42. Lois K, Bukowczan J, Perros P, Jones S, Gunn M & James RA. The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines. Pituitary 2015 18 568-574. (doi:10.1007/s11102-014-0586-5)
43. Dworakowska D, Gueorguiev M, Kelly P, Monson JP, Besser GM, Chew SL, Akker SA, Drake WM, Fairclough PD, Grossman AB et al. Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines. European Journal of Endocrinology 2010 163 21-28. (doi:10.1530/EJE-09-1080)
44. Herrmann BL, Baumann H, Janssen OE, Gorges R, Schmid KW & Mann K. Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up. Experimental and Clinical Endocrinology and Diabetes 2004 112 225-230. (doi:10.1055/s-2004-817967)
45. Tita P, Ambrosio MR, Scollo C, Carta A, Gangemi P, Bondanelli M, Vigneri R, degli Uberti EC & Pezzino V. High prevalence of differentiated thyroid carcinoma in acromegaly. Clinical Endocrinology 2005 63 161-167. (doi:10.1111/cen. 2005.63.issue-2)
46. Ruchala M, Skiba A, Gurgul E, Uruski P, Wasko R & Sowinski J. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer. Neuroendocrinology Letters 2009 30 382-386.
47. Rogozinski A, Furioso A, Glikman P, Junco M, Laudi R, Reyes A & Lowenstein A. Thyroid nodules in acromegaly. Arquivos Brasileiros de Endocrinologia e Metabologia 2012 56 300-304. (doi:10.1590/S0004-27302012000500004)
48. Uchoa HB, Lima GA, Correa LL, Vidal AP, Cavallieri SA, Vaisman M, Buescu A & Gadelha MR. Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian center. Arquivos Brasileiros de Endocrinologia e Metabologia 2013 57 685-690. (doi:10.1590/S0004-27302013000900003)
49. dos Santos MC, Nascimento GC, Nascimento AG, Carvalho VC, Lopes MH, Montenegro R, Montenegro R Jr, Vilar L, Albano MF, Alves AR et al. Thyroid cancer in patients with acromegaly: a case-control study. Pituitary 2013 16 109-114. (doi:10.1007/s11102-012-0383-y)
50. Dogan S, Atmaca A, Dagdelen S, Erbas B & Erbas T. Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients. Endocrine 2014 45 114-121. (doi:10.1007/s12020-013-9981-3)
51. Kim HK, Lee JS, Park MH, Cho JS, Yoon JH, Kim SJ & Kang HC. Tumorigenesis of papillary thyroid cancer is not BRAF-dependent in patients with acromegaly. PLoS ONE 2014 9 e110241. (doi:10.1371/journal.pone.0110241)
52. Mian C, Ceccato F, Barollo S, Watutantrige-Fernando S, Albiger N, Regazzo D, de Lazzari P, Pennelli G, Rotondi S, Nacamulli D et al. AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up. PLoS ONE 2014 9 e101560. (doi:10.1371/journal.pone.0101560)
53. Reverter JL, Fajardo C, Resmini E, Salinas I, Mora M, Llatjös M, Sesmilo G, Rius F, Halperin I, Webb SM et al. Benign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable? PLoS ONE 2014 9 e104174. (doi:10.1371/journal.pone.0104174)
54. Wolinski K, Czarnywojtek A & Ruchala M. Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly - meta-analysis and systematic review. PLoS ONE 2014 9 e88787. (doi:10.1371/journal.pone.0088787)
55. Netea-Maier RT, Aben KK, Casparie MK, den Heijer M, Grefte JM, Slootweg P & Hermus A. Trends in incidence and mortality of thyroid carcinoma in The Netherlands between 1989 and 2003: correlation with thyroid fine-needle aspiration cytology and thyroid surgery. International Journal of Cancer 2008 123 1681-1684. (doi:10.1002/ijc.23678)
56. Dabrowska AM, Tarach JS, Kurowska M & Nowakowski A. Thyroid diseases in patients with acromegaly. Archives of Medical Science 2014 10 837-845. (doi:10.5114/aoms.2013.36924)
57. Colonna M, Uhry Z, Guizard AV, Delafosse P, Schvartz C, Belot A, Grosclaude P & FRANCIM Network. Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France. Cancer Epidemiology 2015 39 511-518. (doi:10.1016/j. canep. 2015.04.015)
58. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016 26 1-133. (doi:10.1089/thy.2015.0020)
59. Aydin K, Aydin C, Dagdelen S, Tezel GG & Erbas T. Genetic alterations in differentiated thyroid cancer patients with acromegaly. Experimental and Clinical Endocrinology and Diabetes 2016 124 198-202. (doi:10.105 5/s-0035-1565061)
60. Chi F, Wu R, Zeng YC, Xing R & Liu Y. Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis. Molecular Biology Reports 2013 40 3583-3590. (doi:10.1007/s11033-012-2432-z)
61. Aguiar-Oliveira MH, Oliveira FT, Pereira RM, Oliveira CR, Blackford A, Valenca EH, Santos EG, Gois-Junior MB, Meneguz-Moreno RA, Araujo VP et al. Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. Journal of Clinical Endocrinology and Metabolism 2010 95 714-721. (doi:10.1210/jc.2009-1879)
62. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW, Hwang D, Martin-Montalvo A, Saavedra J, Ingles S et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer and diabetes in humans. Science Translational Medicine 2011 3 70ra13. (doi:10.1126/scitranslmed.3001845)
63. Boguszewski CL, Fighera TM, Bornschein A, Marques FM, Denes J, Rattenbery E, Maher ER, Stals K, Ellard S & Korbonits M. Genetic studies in a coexistence of acromegaly, pheochromocytoma, gastrointestinal stromal tumor (GIST) and thyroid follicular adenoma. Arquivos Brasileiros de Endocrinologia e Metabologia 2012 56 507-512. (doi:10.1590/S0004-27302012000800008)
64. Hemminki K, Försti A & Ji J. Incidence and familial risks in pituitary adenoma and associated tumors. Endocrine-Related Cancer 2007 14 103-109. (doi:10.1677/ERC-06-0008)
65. Farrell WE. Epigenetic mechanisms of tumorigenesis. Hormone and Metabolic Research 2005 37 361-368. (doi:10.1055/s-2005-870153)
66. Gallagher EJ & LeRoith D. Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer. Diabetes Care 2013 36 (Supplement 2) S233-S239. (doi:10.2337/dcS13-2001)
67. Larsson SC, Orsini N & Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. Journal of the National Cancer Institute 2005 97 1679-1687. (doi:10.1093/jnci/dji375)
68. Colao A, Pivonello R, Auriemma RS, Galdiero M, Ferone D, Minuto F, Marzullo P & Lombardi G. The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients. Journal of Clinical Endocrinology and Metabolism 2007 92 3854-3860. (doi:10.1210/jc.2006-2551)
69. Cheng S, Gomez K, Serri O, Chik C & Ezzat S. The role of diabetes in acromegaly associated neoplasia. PLoS ONE 2015 10 e0127276. (doi:10.1371/journal.pone.0127276)
70. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K & Melmed S. Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2000 85 526-529. (doi:10.1210/jcem.85.2.6363)
71. Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA & Endocrine Society. Acromegaly: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2014 99 3933-3951. (doi:10.1210/jc.2014-2700)
72. Growth Hormone Research Society & Pituitary Society. Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society. Journal of Clinical Endocrinology and Metabolism 2004 89 3099-3102. (doi:10.1210/jc.2003-031138)
73. Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW, Strasburger CJ, Wass JA & Giustina A. A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 2013 16 294-302. (doi:10.1007/s11102-012-0420-x)
74. Provenzale D, Jasperson K, Ahnen DJ, Aslanian H, Bray T, Cannon JA, David DS, Early DS, Erwin D, Ford JM et al. Colorectal cancer screening, version 1.2015. Journal of the National Comprehensive Cancer Network 2015 13 959-968.
75. Ramos O Jr, Boguszewski CL, Teixeira S, De Bem R, Parolim B & Prolla JC. Performance of computed tomographic colonography for the screening of colorectal polyp in acromegalic patients: a prospective study. Arquivos de Gastroenterologia 2009 46 90-96. (doi:10.1590/S0004-28032009000200003)
76. Resmini E, Tagliafico A, Bacigalupo L, Giordano G, Melani E, Rebora A, Minuto F, Rollandi GA & Ferone D. Computed tomography colonography in acromegaly. Journal of Clinical Endocrinology and Metabolism 2009 94 218-222. (doi:10.1210/jc.2008-1479)